Selenium (Se) is an essential trace element that plays an important role in maintaining antioxidant defence, redox balance, immune function and normal cellular metabolism. Selenium is incorporated into several proteins as the amino acid selenocysteine, forming a group of proteins known as selenoproteins. Some experimental studies have shown that selenium compounds may influence the development and behaviour of cancer cells.
Important: Selenium should not be considered a general cancer treatment. Its biological effects depend strongly on its chemical form, dose, nutritional status and cellular environment. High doses of selenium can be toxic.
1. Role of Selenium in Antioxidant Defence
Selenium is an essential component of several antioxidant enzymes, particularly glutathione peroxidases (GPx) and thioredoxin reductases (TrxR). These enzymes help regulate reactive oxygen species (ROS) and maintain cellular redox balance.
By controlling oxidative stress, selenium contributes to the protection of normal cells from oxidative damage. However, certain selenium compounds at pharmacological concentrations can also increase oxidative stress selectively in cancer cells. This difference is one of the mechanisms being investigated in selenium-based anticancer research.
2. Induction of Oxidative Stress in Cancer Cells
Some selenium compounds can undergo redox reactions inside cells and generate reactive oxygen species (ROS). Cancer cells often have altered redox metabolism and may be more sensitive to additional oxidative stress than normal cells.
At sufficiently high pharmacological concentrations, certain selenium compounds may therefore disturb the redox balance of tumour cells, leading to cellular damage and activation of cell-death pathways.
General mechanism:
Selenium compound → redox reactions → increased ROS → oxidative stress → damage to cellular components → activation of cell-death pathways
3. Induction of Apoptosis
Apoptosis is a regulated form of programmed cell death. Experimental studies have shown that some selenium compounds can promote apoptosis in cancer cells by affecting mitochondrial function, redox signalling and proteins involved in cell survival and death.
Changes in the balance between pro-apoptotic and anti-apoptotic proteins can promote activation of caspases, which are important enzymes in the execution of apoptosis.
4. Inhibition of Cancer Cell Proliferation
Certain selenium compounds have been reported in experimental systems to inhibit the proliferation of cancer cells. This may involve interference with cell-cycle progression, alteration of signalling pathways and changes in the expression of proteins that regulate cell growth.
The effects are dependent on the selenium compound and its concentration; therefore, results obtained with one selenium compound cannot automatically be applied to all forms of selenium.
5. Effects on Cell-Cycle Regulation
Some selenium compounds can affect the progression of cancer cells through different stages of the cell cycle. Experimental studies have reported cell-cycle arrest at particular phases, which can reduce the ability of tumour cells to multiply.
This activity may involve changes in cell-cycle regulatory proteins and signalling pathways responsible for DNA synthesis and cell division.
6. Inhibition of Angiogenesis
Angiogenesis is the formation of new blood vessels. Tumours can stimulate angiogenesis to obtain oxygen and nutrients required for continued growth.
Some experimental studies suggest that particular selenium compounds may interfere with signalling mechanisms involved in angiogenesis. Reduction of tumour-associated blood-vessel formation could potentially restrict tumour growth, although this effect depends on the selenium compound and experimental conditions.
7. Modulation of Molecular Signalling Pathways
Selenium compounds can influence several cellular signalling pathways involved in proliferation, inflammation, apoptosis and cellular stress. Reported molecular targets include pathways associated with NF-κB, PI3K/Akt, MAPK and other redox-sensitive signalling systems.
Because these pathways regulate many cellular processes, their modulation may contribute to the observed anticancer effects of certain selenium compounds in experimental models.
8. Possible Effects on Metastasis
Metastasis is the spread of cancer cells from the primary tumour to other parts of the body. Experimental research has investigated whether selenium compounds can affect processes involved in cancer-cell migration, invasion and epithelial-to-mesenchymal transition (EMT).
Some selenium compounds have shown inhibitory effects on these processes in laboratory and animal models. However, these findings do not establish selenium as a proven treatment for preventing metastasis in humans.
9. Selenium Compounds and Their Experimental Anticancer Effects
| Selenium form/compound | Reported experimental effect |
|---|---|
| Selenite | Can alter cellular redox balance and, at pharmacological concentrations, promote oxidative stress and apoptosis in experimental cancer models. |
| Selenate | Has been investigated for effects on cellular metabolism and signalling in experimental systems. |
| Selenomethionine | An organic selenium form involved in selenium nutrition; its cancer-prevention effects have been investigated, with results varying among studies and populations. |
| Selenium nanoparticles | Investigated experimentally for selective cytotoxicity, oxidative-stress modulation and drug-delivery applications. |
10. Selenium and DNA Damage
Some selenium compounds can influence oxidative stress and DNA-damage responses. At pharmacological concentrations, increased oxidative stress may contribute to DNA damage in susceptible cancer cells and activate cellular mechanisms leading to cell-cycle arrest or apoptosis.
This mechanism should be distinguished from the nutritional role of selenium, where selenoproteins contribute to normal cellular antioxidant and redox functions.
11. Selenium in Cancer Chemoprevention Research
The potential role of selenium in cancer chemoprevention has been studied because selenium is an essential micronutrient and is involved in antioxidant and cellular defence systems. However, human clinical studies have not consistently shown that selenium supplementation prevents cancer in the general population.
Therefore, selenium supplementation should not be recommended as a substitute for established cancer-prevention measures or medical treatment.
12. Factors Affecting Selenium's Biological Activity
- Chemical form: Different selenium compounds have different biological and toxicological properties.
- Dose: Nutritional and pharmacological doses can produce very different effects.
- Selenium status: The response can depend on the individual's existing selenium status.
- Cell type: Cancer cells and normal cells may respond differently to selenium compounds.
- Redox state: Selenium can participate in cellular redox reactions.
- Interaction with other pathways: Selenium can influence antioxidant, apoptotic and signalling pathways.
Conclusion
Selenium has attracted considerable interest in cancer research because of its role in redox regulation, antioxidant defence and cellular signalling. Certain selenium compounds, particularly at pharmacological concentrations, have demonstrated experimental anticancer effects such as induction of oxidative stress, apoptosis, cell-cycle arrest and inhibition of tumour-cell proliferation and invasion.
However, these effects are strongly dependent on the chemical form and dose of selenium. Nutritional selenium and pharmacological selenium compounds should not be treated as equivalent. Although selenium remains an important subject of cancer chemoprevention and therapeutic research, current evidence does not support using selenium supplements as a general treatment for cancer.
Read also Role of Selenium in Biological System
Download PDF Anti-Cancer Activity of Selenium
Bioinorganic Chemistry B.Sc. & M.Sc.